Use of Affymetrix arrays in the diagnosis of gene copy-number variation

Farah R. Zahir, Marco A. Marra

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Diagnosing constitutional pathogenic copy number variants (CNVs) requires detecting submicroscopic segmental chromosomal imbalances. The Affymetrix GeneChip mapping array was one of the initial microarray platforms used to measure duplication and deletion of genetic material in DNA samples. Unlike oligonucleotide microarrays from NimbleGen and Agilent, developed around the same time to infer copy number status for the DNA sequence covered by the probe, the Affymetrix GeneChip system used 25-mer oligonucleotide probes designed to interrogate SNPs. Thus, it was possible to use the Affymetrix 'SNP chips' to both identify SNPs and to identify copy number status. Affymetrix now offers the CytoScan microarray platforms, which are optimized for copynumber analyses, and provides accompanying software. They also offer several other microarray platforms suitable for copy-number analyses. Here we discuss the application of the CytoScan high-density (HD) platform for the detection of genomic imbalance. We provide an overview of the sequence of computational analyses involved in identifying pathogenic CNVs and highlight important parameters for consideration in assessing the pathogenicity of a detected CNV.

Original languageEnglish
Pages (from-to)8.13.1-8.13.13
JournalCurrent Protocols in Human Genetics
Volume2015
DOIs
Publication statusPublished - 2015
Externally publishedYes

Fingerprint

Gene Dosage
Single Nucleotide Polymorphism
Oligonucleotide Probes
Oligonucleotide Array Sequence Analysis
Sequence Analysis
Virulence
Software
DNA
Genes

Keywords

  • Affymetrix
  • Chromosome aberrations
  • CMA
  • Cytoscan
  • Software

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Use of Affymetrix arrays in the diagnosis of gene copy-number variation. / Zahir, Farah R.; Marra, Marco A.

In: Current Protocols in Human Genetics, Vol. 2015, 2015, p. 8.13.1-8.13.13.

Research output: Contribution to journalArticle

@article{4e0212a6c4134c6ba90b7d383e379c45,
title = "Use of Affymetrix arrays in the diagnosis of gene copy-number variation",
abstract = "Diagnosing constitutional pathogenic copy number variants (CNVs) requires detecting submicroscopic segmental chromosomal imbalances. The Affymetrix GeneChip mapping array was one of the initial microarray platforms used to measure duplication and deletion of genetic material in DNA samples. Unlike oligonucleotide microarrays from NimbleGen and Agilent, developed around the same time to infer copy number status for the DNA sequence covered by the probe, the Affymetrix GeneChip system used 25-mer oligonucleotide probes designed to interrogate SNPs. Thus, it was possible to use the Affymetrix 'SNP chips' to both identify SNPs and to identify copy number status. Affymetrix now offers the CytoScan microarray platforms, which are optimized for copynumber analyses, and provides accompanying software. They also offer several other microarray platforms suitable for copy-number analyses. Here we discuss the application of the CytoScan high-density (HD) platform for the detection of genomic imbalance. We provide an overview of the sequence of computational analyses involved in identifying pathogenic CNVs and highlight important parameters for consideration in assessing the pathogenicity of a detected CNV.",
keywords = "Affymetrix, Chromosome aberrations, CMA, Cytoscan, Software",
author = "Zahir, {Farah R.} and Marra, {Marco A.}",
year = "2015",
doi = "10.1002/0471142905.hg0813s85",
language = "English",
volume = "2015",
pages = "8.13.1--8.13.13",
journal = "Current Protocols in Human Genetics",
issn = "1934-8266",
publisher = "John Wiley and Sons Inc.",

}

TY - JOUR

T1 - Use of Affymetrix arrays in the diagnosis of gene copy-number variation

AU - Zahir, Farah R.

AU - Marra, Marco A.

PY - 2015

Y1 - 2015

N2 - Diagnosing constitutional pathogenic copy number variants (CNVs) requires detecting submicroscopic segmental chromosomal imbalances. The Affymetrix GeneChip mapping array was one of the initial microarray platforms used to measure duplication and deletion of genetic material in DNA samples. Unlike oligonucleotide microarrays from NimbleGen and Agilent, developed around the same time to infer copy number status for the DNA sequence covered by the probe, the Affymetrix GeneChip system used 25-mer oligonucleotide probes designed to interrogate SNPs. Thus, it was possible to use the Affymetrix 'SNP chips' to both identify SNPs and to identify copy number status. Affymetrix now offers the CytoScan microarray platforms, which are optimized for copynumber analyses, and provides accompanying software. They also offer several other microarray platforms suitable for copy-number analyses. Here we discuss the application of the CytoScan high-density (HD) platform for the detection of genomic imbalance. We provide an overview of the sequence of computational analyses involved in identifying pathogenic CNVs and highlight important parameters for consideration in assessing the pathogenicity of a detected CNV.

AB - Diagnosing constitutional pathogenic copy number variants (CNVs) requires detecting submicroscopic segmental chromosomal imbalances. The Affymetrix GeneChip mapping array was one of the initial microarray platforms used to measure duplication and deletion of genetic material in DNA samples. Unlike oligonucleotide microarrays from NimbleGen and Agilent, developed around the same time to infer copy number status for the DNA sequence covered by the probe, the Affymetrix GeneChip system used 25-mer oligonucleotide probes designed to interrogate SNPs. Thus, it was possible to use the Affymetrix 'SNP chips' to both identify SNPs and to identify copy number status. Affymetrix now offers the CytoScan microarray platforms, which are optimized for copynumber analyses, and provides accompanying software. They also offer several other microarray platforms suitable for copy-number analyses. Here we discuss the application of the CytoScan high-density (HD) platform for the detection of genomic imbalance. We provide an overview of the sequence of computational analyses involved in identifying pathogenic CNVs and highlight important parameters for consideration in assessing the pathogenicity of a detected CNV.

KW - Affymetrix

KW - Chromosome aberrations

KW - CMA

KW - Cytoscan

KW - Software

UR - http://www.scopus.com/inward/record.url?scp=84941787858&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941787858&partnerID=8YFLogxK

U2 - 10.1002/0471142905.hg0813s85

DO - 10.1002/0471142905.hg0813s85

M3 - Article

VL - 2015

SP - 8.13.1-8.13.13

JO - Current Protocols in Human Genetics

JF - Current Protocols in Human Genetics

SN - 1934-8266

ER -